Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Ubiquinone/Vitamin E (moderate)
Dipyridamole (severe)
Celecoxib (moderate)
Fluoxetine (moderate)
Citalopram (moderate)
Clopidogrel (severe)
Prasugrel (severe)
Warfarin (severe)
Ibuprofen (moderate)
Diclofenac (moderate)
Abciximab (severe)
Magnesium salicylate (moderate)
Tenecteplase (severe)
This medicine is used to decrease the risk of death and a new episode of a heart attack in patients suffering from an acute coronary syndrome, including patients who are to be managed medically and those undergoing percutaneous coronary intervention.
This medicine is used to decrease the risk of death, a new episode of a heart attack, or a need for urgent intervention in patients undergoing percutaneous coronary intervention, including those undergoing stenting procedure.
Abdominal pain and discomfort
Back pain (severe)
Bleeding from the bladder (severe)
Bleeding gums
Blood in urine (severe)
Bloody or tarry stools (severe)
Blurred vision
Constipation
Presence of blood in cough (severe)
Dizziness when getting up suddenly from a sitting position
Headache
Heavy menstrual bleeding (severe)
Paralysis (severe)
Unusual bleeding or bruising (severe)
Shortness of breath
Unusual tiredness or weakness
Pinpoint red spots on skin
Difficulty in swallowing (severe)
Fast/irregular heart beat (severe)
Severe skin rash and hives (severe)
Puffing or swelling of eyelids (rare)
Slurred speech (severe)
Inability to move the arms, legs, or facial muscle (severe)
This medicine is not recommended for use in patients with a known allergy to FIBATIDE 2mg|ml Injection 10ml vial or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with a history of bleeding disorders due to blood coagulation issues (bleeding diathesis) or active abnormal bleeding within the previous 30 days due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients suffering from severe hypertension (high blood pressure levels more than 200/110 mm Hg) that is not adequately controlled using appropriate medication due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients who have undergone major surgery within the preceding 6 weeks due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with a history of stroke within the past 30 days or any history of hemorrhagic stroke (an emergency condition where blood vessels rupture within the brain) due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients receiving or patients about to receive other parenteral GP IIb/IIIa inhibitors since it may worsen the patient's condition.
This medicine is not recommended for use in patients who are undergoing dialysis or have a dependency on this procedure due to the increased risk of worsening of the patient’s condition.